Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frits van Rhee

Showing results (261-270 of 274) with videos related to

Pageof 28
Sort By:
Cell Reports. Medicine|December 30, 2020
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare DisorderSheila K Pierson, Johnson S Khor, Jasira Ziglar, et al.
American Journal of Hematology|April 26, 2022
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experienceMeera Mohan, Melody Renee Becnel, Urvi A Shah, et al.
Plos Medicine|November 4, 2020
Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trialsSamuel A Danziger, Mark McConnell, Jake Gockley, et al.
Nature Communications|December 13, 2022
Author Correction: Functional dissection of inherited non-coding variation influencing multiple myeloma riskRam Ajore, Abhishek Niroula, Maroulio Pertesi, et al.
Nature Communications|January 11, 2022
Functional dissection of inherited non-coding variation influencing multiple myeloma riskRam Ajore, Abhishek Niroula, Maroulio Pertesi, et al.
Future Oncology (London, England)|March 26, 2021
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myelomaRoman Hájek, Jiří Minařík, Jan Straub, et al.
Nature Communications|August 17, 2023
Resolving the spatial architecture of myeloma and its microenvironment at the single-cell levelLukas John, Alexandra M Poos, Alexander Brobeil, et al.
Blood|January 15, 2017
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman diseaseDavid C Fajgenbaum, Thomas S Uldrick, Adam Bagg, et al.
Nature Communications|January 21, 2021
Author Correction: Accelerated single cell seeding in relapsed multiple myelomaHeather J Landau, Venkata Yellapantula, Benjamin T Diamond, et al.
Nature Communications|July 19, 2020
Accelerated single cell seeding in relapsed multiple myelomaHeather J Landau, Venkata Yellapantula, Benjamin T Diamond, et al.
Pageof 28

Showing results (261-270 of 274) with videos related to

Sort By:
Pageof 28
Cell Reports. Medicine|December 30, 2020
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare DisorderSheila K Pierson, Johnson S Khor, Jasira Ziglar, et al.
American Journal of Hematology|April 26, 2022
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experienceMeera Mohan, Melody Renee Becnel, Urvi A Shah, et al.
Plos Medicine|November 4, 2020
Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trialsSamuel A Danziger, Mark McConnell, Jake Gockley, et al.
Nature Communications|December 13, 2022
Author Correction: Functional dissection of inherited non-coding variation influencing multiple myeloma riskRam Ajore, Abhishek Niroula, Maroulio Pertesi, et al.
Nature Communications|January 11, 2022
Functional dissection of inherited non-coding variation influencing multiple myeloma riskRam Ajore, Abhishek Niroula, Maroulio Pertesi, et al.
Future Oncology (London, England)|March 26, 2021
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myelomaRoman Hájek, Jiří Minařík, Jan Straub, et al.
Nature Communications|August 17, 2023
Resolving the spatial architecture of myeloma and its microenvironment at the single-cell levelLukas John, Alexandra M Poos, Alexander Brobeil, et al.
Blood|January 15, 2017
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman diseaseDavid C Fajgenbaum, Thomas S Uldrick, Adam Bagg, et al.
Nature Communications|January 21, 2021
Author Correction: Accelerated single cell seeding in relapsed multiple myelomaHeather J Landau, Venkata Yellapantula, Benjamin T Diamond, et al.
Nature Communications|July 19, 2020
Accelerated single cell seeding in relapsed multiple myelomaHeather J Landau, Venkata Yellapantula, Benjamin T Diamond, et al.
Pageof 28